These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1796241)

  • 1. Screening for HTLV-1 in healthy blood donors in Trinidad and Tobago, West Indies.
    Daisley H; Charles W; Landeau P; Jackman L; Batson M; Gomez-Adams K
    Trop Med Parasitol; 1991 Dec; 42(4):404-6. PubMed ID: 1796241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.
    Rouet F; Meertens L; Courouble G; Herrmann-Storck C; Pabingui R; Chancerel B; Abid A; Strobel M; Mauclere P; Gessain A
    J Clin Microbiol; 2001 Apr; 39(4):1247-53. PubMed ID: 11283036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of HTLV-I and its associated risk factors in Trinidad and Tobago.
    Blattner WA; Saxinger C; Riedel D; Hull B; Taylor G; Cleghorn F; Gallo R; Blumberg B; Bartholomew C
    J Acquir Immune Defic Syndr (1988); 1990; 3(11):1102-8. PubMed ID: 2213511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of evidence of HTLV-I antibodies in the Finnish population.
    Leinikki P; Mattila E; Koistinen J; Leikola J; Kantanen ML; Brummer-Korvenkontio H
    Scand J Infect Dis; 1989; 21(5):515-9. PubMed ID: 2685986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
    Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
    Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Search for antibodies against human T-cell lymphotropic virus type I (HTLV-I) in blood donors and risk groups].
    Silva Cabrera E; Pérez Guevara MT; Lubián Caballero AL; de la Fuente Arzola JL; Navea Leyva L; Cruz Sui O
    Rev Cubana Med Trop; 1997; 49(1):24-7. PubMed ID: 9685956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV-I in multiply transfused patients in Trinidad and Tobago.
    Barbara JA
    Vox Sang; 1994; 66(2):152. PubMed ID: 7910425
    [No Abstract]   [Full Text] [Related]  

  • 9. Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico.
    Trejo-Avila LM; Fuentes-Pensamiento R; Scorro Flores-Castañeda M; Diaz-Mendoza ML; Zapata-Benavides P; Tamez-Guerra RS
    Arch Med Res; 1996; 27(1):97-9. PubMed ID: 8867376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
    Fawaz NA; Tamim H; Almawi WY
    Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HTLV-I antibody screening of blood donors].
    Schwarzfischer G; Schätzl H; Bäcker U; Weise W; von der Helm K; Deinhardt F
    Beitr Infusionsther; 1991; 28():29-31. PubMed ID: 1725641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
    Kumar H; Gupta PK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-I seroprevalence in the Sultanate of Oman.
    Knox-Macaulay H; McDonald R; al-Busaidy S; Ali N
    Scand J Infect Dis; 1997; 29(3):217-8. PubMed ID: 9255877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of human T-lymphotropic virus type I (HTLV-I) in Saudi Arabia.
    Arif M; Ramia S
    Ann Trop Med Parasitol; 1998 Apr; 92(3):305-9. PubMed ID: 9713546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-1 in multiply transfused patients in Trinidad and Tobago, West Indies.
    Daisley H; Charles W; Landeau P; Jackman L; Gomez-Adams K; Batson M
    Vox Sang; 1993; 64(3):189-90. PubMed ID: 8484256
    [No Abstract]   [Full Text] [Related]  

  • 16. Decline in the positive rate of human T-lymphotropic virus type-1 (HTLV-1) antibodies among blood donors in Nagasaki.
    Chiyoda S; Kinoshita K; Egawa S; Inoue J; Watanabe K; Ifuku M
    Intern Med; 2001 Jan; 40(1):14-7. PubMed ID: 11201362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of antibodies to HTLV-1 in South American Indians (Mapuches) from Chile.
    Inostroza J; Diaz P; Saunier C
    Scand J Infect Dis; 1991; 23(4):507-8. PubMed ID: 1957135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Absence of HTLV-I/II virus circulation in blood donors from the provinces of Santa Fe and Santiago del Estero].
    Gastaldello R; Fazzola P; Caeiro L; Maturano E; Perez De Rosas A; Fernandez I; Racca R; Rodriguez MB; Molina M; Alonso S; Gallego S
    Rev Argent Microbiol; 2002; 34(2):107-9. PubMed ID: 12180256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-I antibody study in normal individuals and unselected hospital patients in Malaysia.
    Yap SF; Peh SC; Chan L; Wong HC; How VJ; Looi LM
    Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):26-9. PubMed ID: 1355930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of anti-HTLV-1 in physical-checkup individuals and blood donors in Taiwan.
    Yung CH; Chow MP; Hu HY; Tzeng JL; Wu YS; Lyou JY; Liu WT
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):244-51. PubMed ID: 1342641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.